| Human Cell Design–Revvity: investment, 202609–acquisition €na of Human Cell Design by Revvity |
2026-09-09 |
| MLM Medical Labs–Labcorp: investment, 2022609 acquisition €na of MLM Medical Labs by Labcorp |
2026-09-08 |
| Adaptyv Biosystems–Y Combinator: investment, 202608 financing round Series A totalling $40m incl existing + co-investor Y Combinator |
2026-08-25 |
| Shimadzu–Newomics: electrospray ionisation technology, 202608– collab co-marketing Newomics technologies with Shimadzu Q-TOF + TQ LC-MS systems |
2026-08-24 |
| Atinary Technologies–Bruker: investment, 202608 minority investment €na by Bruker in connection with strategic collaboration |
2026-08-11 |
| Bruker–Atinary Technologies: AI-based lab software, 202608– strategic collab integrating SDLabs with Chemspeed robotics + Bruker FT-NMR |
2026-08-11 |
| Mimetas–Bruker: investment, 202606 majority investment €na by Bruker |
2026-08-10 |
| Agilent–Leucadia: investor conference, 202606 supply service Agilent participates in Jefferies Global Healthcare Conference in NY |
2026-06-03 |
| Danaher–Ion Opticks: liquid chromatography, 202606– ww reseller + co-marketing agreem for Auroro Series SX colums + HeatSync w Sciex ZenoTOF systems |
2026-06-02 |
| Danaher–mzio: mass spectrometry software, 202605 collab existent with Sciex on mzio industry-agnostic solutions |
2026-05-20 |
| Alamar Biosciences–SEVERAL: investment, 202604 IPO $191.25m+$28.688m with 11.25m+1.688m shares common stock incl full over-allotment at Nasdaq |
2026-04-20 |
| Tecan–Nvidia: AI-based lab management, 202603– strategic collab AI-powered lab automation platforms |
2026-03-17 |
| Biocare Medical–Agilent: investment, 200603 acquisitiion $950m in cash by Agilent from investor group led by Excellere Parnters + GHO Capital Partners |
2026-03-09 |
| Univ Kiel–Bruker: CellScape XR platform, 2002602 supply + collab research UKSH Kiel has been early customer |
2026-02-25 |
| Buck Institute–Nautilus Biotechnology: proteomics instrument, 202602 supply existent Buck Institute is early customer for new Voyager Platform |
2026-02-24 |
| Cubase Bio–Illumina: investment, 202602 financing totalling €3.9m in private capital + convertibles incl co-investor Illumina Ventures |
2026-02-17 |
| Masimo–Danaher: investment, 202602– acquisition $9.9b in cash net of cash/debt at $180/share SIGNED |
2026-02-17 |
| Agilent–ABB: lab automation technology, 202602 collab existent integration of Agilent instruments into muli-vendor systems of ABB Robotics |
2026-02-04 |
| Agilent–Bico: lab automation technology, 202602 collab existent integration of Agilent instruments into muli-vendor systems of Biosero |
2026-02-04 |
| Agilent–HighRes Biosolutions: lab automation technology, 202602 collab existent integration of Agilent instruments into muli-vendor systems of HRBS |
2026-02-04 |
| Agilent–UniteLabs: lab automation technology, 202602 collab existent integration of Agilent instruments into muli-vendor systems of Unite Labs |
2026-02-04 |
| Agilent–Siemens: laboratory software, 202602– collab expansion to enhance interoperability of OpenLab CDS with Virscidian Analytical Studio s/w |
2026-02-03 |
| Accellix–Mérieux: investment, 202601 acquisition remaining 90% of Accellix by bioMérieux for €35m in cash |
2026-01-22 |
| Agilent–JPMorgan Chase: investor conference, 202601 supply service Agilent presents at JP Morgan Healthcare Conference 2026 |
2026-01-13 |
| Danaher–JPMorgan Chase: investor conference, 202601 supply service Danaher presents at JP Morgan Healthcare Conference 2026 |
2026-01-13 |
| PathoQuest–Charles River: investment, 202601– acquisition of PathoQuest by Charles River SIGNED |
2026-01-12 |
| TOFwerk–Bruker: investment, 202601 acquisition of remaining 60% ownership stake €na by Bruker |
2026-01-08 |
| Molzym–Bruker: investment, 202511 acquisition of Molzym by Bruker |
2025-11-26 |
| Exact Sciences–Abbott: investment, 202511– acquisition $21b via cash tender offer at $105/share ANNOUNCED |
2025-11-20 |
| ACD/Labs–Revvity: investment, 202511– acquisition of ACD/Labs by Revvity definitive agreement announced |
2025-11-10 |
| Clario–Thermo Fisher: investment, 202510– acquisition $9b in cash plus earnouts and milestones SIGNED |
2025-10-29 |
| Repligen–Bank of America: investor conference, 202509 supply service Repligen to present at BofA Global Healthcare Conference London 2025 |
2025-09-25 |
| Repligen–Deutsche Bank: investor conference, 202509 supply service Repligen to present at Deutsche Bank Healthcare Summit 2025 |
2025-09-10 |
| Nautilus Biotechnology–Morgan Stanley: investor conference, 202509 supply service Nautilus to participate in MS Global Healthcare Conference |
2025-09-08 |
| Repligen–Wells Fargo: investor conference, 202509 supply service Repligen to present at Wells Fargo Healthcare Conference 2025 |
2025-09-04 |
| Dash Bio–Aligned Fund: investment, 202507 financing round totalling $11m incl lead investor The Aligned Fund |
2025-07-23 |
| Dash Bio–Cybernetix Ventures: investment, 202507 financing round totalling $11m incl co-investor Cybernetix Ventures |
2025-07-23 |
| Dash Bio–Drive Capital: investment, 202507 financing round totalling $11m incl co-investor Drive Capital |
2025-07-23 |
| Dash Bio–Freestyle Capital: investment, 202507 financing round totalling $11m incl co-investor Freestyle Capital |
2025-07-23 |
| Dash Bio–LifeX Ventures: investment, 202507 financing round totalling $11m incl co-investor LifeX Ventures |
2025-07-23 |
| Dash Bio–SEVERAL: investment, 202507 financing round $11m led by The Aligned Fund |
2025-07-23 |
| Dash Bio–Swift Ventures: investment, 202507 financing round totalling $11m incl co-investor Swift Ventures |
2025-07-23 |
| Becton Dickinson–Waters: investment, 202507–202602 merger acquisition of BD Biosciences & Diagnostics by Waters valued at $17.5b with $4b in cash |
2025-07-14 |
| Applied Technical Services–SGS: investment, 202507–202601 acquisition $1.235b cash-/debt-free with <$100m in shares + rest in cash |
2025-07-02 |
| Standard BioTools–Illumina: investment, 202506– acquisition of SomaLogic by Illumina for $350m cash upfront + $75m milestones |
2025-06-23 |
| Day Zero Diagnostics–Mérieux: investment, 202506 acquisition <$25m of assets of Day Zero Diagnostics by bioMérieux |
2025-06-16 |
| Synexa Life Sciences–Waters: mass spectrometer, 202506 supply + collab as one of first customers for new Xevo TQ Absolute XR mass spectrometer |
2025-06-10 |
| Agilent–Leucadia: investor conference, 202506 supply service Agilent participates in Jefferies Global Healthcare Conference in NY |
2025-06-04 |
| Biocrates–Bruker: investment, 202506 acquisition €na by Bruker Corporation |
2025-06-03 |
| Mobilion–Scott Partnership: public relations, 202505 service existent Scott PR is media contact |
2025-05-27 |
| Halo Labs–Waters: investment, 202505 acquisiton of Halo Labs by Waters |
2025-05-21 |
| Bruker–Siscapa: MS-based proteomics, 2020505– collab strategic Biognosys beomces preferred service provider for Siscapa tech to biopharma customers |
2025-05-19 |
| PeptiSystems–Asahi Kasei: peptide synthesis, 202505– collab ww excl integration of Thesys ACS Ergo synthesis column of AKBA into PeptiPro platform |
2025-05-15 |
| Biotage–KKR: investment, 202504– public takeover offer by RWK BidCo AB valuing Biotage at SEK11.6b at SEK1.65/share (KKR already owns 17%) |
2025-04-22 |
| Recipe–Bruker: investment, 202504 majority investment €na by Bruker in Recipe Chemicals + Instruments GmbH |
2025-04-16 |
| Ridom–Bruker: investment, 202504 majority investment €na by Bruker in Ridom GmbH |
2025-04-11 |
| Bico–Sartorius: investment, 202504–202507 acquisition 100% of MatTek Corp + Visikol Inc on cash/debt-free basis for $80m by Sartorius Lab Holding GmbH |
2025-04-04 |
| Dotmatics–Siemens: investment, 202502–202507 acquisition $5.1b of Dotmatics from Insight Partners |
2025-04-02 |
| OmicScouts–Momentum Biotechnologies: investment, 202503 acquisition of OmicScouts GmbH by Momentum Biotechnologies |
2025-03-05 |
| Solventum–Thermo Fisher: investment, 202502– acquisition $4.1b in cash of purification + filtration business by Thermo Fisher |
2025-02-25 |
| Mobilion–ICR: public relations, 202502 service existent ICR Healthcare is media contact |
2025-02-13 |
| Stellaromics–Catalyst4: investment, 202502 financing round Series B totalling $80m incl lead investor Catalyst4 |
2025-02-11 |
| Stellaromics–Oak Street Communications: public relations, 202502 service existent Oak Street is media contact for Stellaromics |
2025-02-11 |
| Stellaromics–SEVERAL: investment, 202502 financing round Series B $80m led by Catalyst4 |
2025-02-11 |
| Stellaromics–Stanford Univ: investment, 202502 financing round Series B totalling $80m incl co-investor Stanford University Ventures |
2025-02-11 |
| Owlstone–Gates Foundation: grant, 202404– initial $1.5m grant to develop breat-based diagnostics for developing countries from Gates Foundation |
2025-01-15 |
| Agilent–JPMorgan Chase: investor conference, 202501 supply service Agilent presents at JP Morgan Healthcare Conference 2025 |
2025-01-14 |
| Mérieux–JPMorgan Chase: investor conference, 202501 supply service bioMérieux presents at JP Morgan Healthcare Conference 2025 |
2025-01-14 |
| Bruker–JPMorgan Chase: investor conference, 202501 supply service Bruker presents at JP Morgan Healthcare Conference 2025 |
2025-01-13 |
| Akoya Biosciences–Quanterix: investment, 202501– merger acquisition with former Quanterix shareholders owning 70% ANNOUNCED |
2025-01-10 |
| miDiagnostics–Thermo Fisher: investment, 202412 financing round Series D totalling €30m incl lead investor Thermo Fisher Scientific |
2024-12-04 |
| Tagomics–Agilent: genomic technology, 202411– collab co-marketing agreem of Interlace multiomics services using Agilent genomic profiling products |
2024-11-20 |
| Mainz Biomed–Thermo Fisher: colorectal cancer screening test, 202411– collab developm + commercialisation assays for mRNA-based CRC screening tests |
2024-11-12 |
| PrognomiQ–aMoon: investment, 202411 financing round Series D totalling $34m incl existing + co-investor aMoon |
2024-11-05 |
| PrognomiQ–Bruker: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Bruker |
2024-11-05 |
| PrognomiQ–Catalio Capital: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Catalio Capital Management |
2024-11-05 |
| PrognomiQ–Invus Group: investment, 202411 financing round Series D totalling $34m incl existing + co-investor Invus |
2024-11-05 |
| PrognomiQ–OTHER: investment, 202411 financing round Series D totalling $34m incl new large strategic diagnostics investor |
2024-11-05 |
| PrognomiQ–SEVERAL: investment, 202411 financing round Series D $34m led by Seer Inc |
2024-11-05 |
| Danaher–Ion Opticks: liquid chromatography, 202410– collab co-marketing of Aurora Series XS LC columns with ZenoTOF line MS systems of Sciex |
2024-10-25 |
| Dash Bio–SEVERAL: investment, 202410 seed financing round $6.5m led by Freestyle Capital |
2024-10-24 |
| Bureau Veritas–Mérieux: investment, 202410– acquisition €360m of global food testing of Bureau Veritas by Mérieux NutriSciences |
2024-10-07 |
| Virscidian–Dotmatics: investment, 202409 acquisition of Virscidian by Dotmatics |
2024-09-25 |
| Bruker–Morgan Stanley: investor conference, 202409 supply service Bruker presents at Morgan Stanley Global Healthcare Conference NY |
2024-09-06 |
| Bruker–Wells Fargo: investor conference, 202409 supply service Bruker presents at Wells Fargo Healthcare Conference in Boston |
2024-09-04 |
| Genedata–Danaher: investment, 202408 acquisition of Genedata that will join Danaher’s Life Science segment |
2024-08-19 |
| Standard BioTools–UBS: investor conference, 202408 supply service Standard BioTech participates in UBS Genomic Medicine Summit |
2024-08-14 |
| Allogene Therapeutics–Baird: investor conference, 202408 supply service Allogene participates in Baird 2024 Global Healthcare Conference |
2024-08-13 |
| Allogene Therapeutics–Canaccord Genuity: investor conference, 202408 supply service Allogene participates in Canaccord Genuity Growth Conference |
2024-08-13 |
| Standard BioTools–Canaccord Genuity: investor conference, 202408 supply service Standard BioTech participates in Canaccord Genuity Growth Conference |
2024-08-13 |
| Novalix–Bruker: investment, 202408 strategic minority investment €na by Bruker |
2024-08-07 |
| Thermo Fisher–Biomatter Designs: enzyme design, 202408 supply existent customer Thermo Fisher |
2024-08-05 |
| EasyPanel–Dotmatics: investment, 202407 acquisition of EasyPanel by Dotmatics |
2024-07-30 |
| Agilent–Sigsense Technologies: lab management software, 202407 supply existent Sigsense technology available via Agilent CrossLab Connect |
2024-07-29 |
| Sigsense Technologies–Agilent: investment, 202407 acquisition €na of Sigsense by Agilent |
2024-07-29 |
| Biovectra–Agilent: investment, 202407– acquisition of Biovectra for $925m by Agilent from H.I.G. Capital |
2024-07-22 |
| CytoReason–Thermo Fisher: investment, 202407 financing round totalling $80m incl investor Thermo Fisher Scientific |
2024-07-17 |
| ChemAxon–Certara: investment, 202407–202410 acquisition of ChemAxon by Certara |
2024-07-09 |
| Sartorius–Nvidia: AI-based drug discovery + manufacturing, 202405– collab expansion incl adaption of Nvidia Clara Suite + DGX platform |
2024-05-16 |
| Owlstone–Gates Foundation: investment, 202501 financing round Series E first closing totalling $27m incl $5m from new + co-investor Gates Foundation |
2024-04-25 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
